Terlipressin‐induced skin necrosis in cirrhotic patients—A case report and comprehensive literature review [PDF]
Clinical Case ReportsKey Clinical Message The occurrence of terlipressin‐induced skin necrosis in cirrhotic patients is a rare but serious adverse event that warrants further investigation.
Ashraf I. Ahmed +6 more
doaj +3 more sources
Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis [PDF]
Frontiers in PharmacologyBackgroundHepatorenal syndrome (HRS) bears a very poor prognosis with unmet need for safe and effective therapies. This systematic review and meta-analysis aimed to re-assess safety and efficacy of terlipressin versus placebo or noradrenaline for HRS ...
Yue-Meng Wan +5 more
doaj +3 more sources
Hyponatraemia Induced by Terlipressin in Patients Diagnosed with Decompensated Liver Cirrhosis and Acute Variceal Bleeding [PDF]
MedicinesBackground: Hyponatraemia is a rare but potentially life-threatening complication of terlipressin therapy. Case history: In the current case, a 39-year-old female with decompensated liver cirrhosis (Child-Pugh C) and acute variceal bleeding experienced a
Mahmoud Elshehawy +4 more
doaj +4 more sources
Practice guidance for the use of terlipressin for liver cirrhosis–related complications [PDF]
Therapeutic Advances in Gastroenterology, 2022 Background: Liver cirrhosis is a major global health burden worldwide due to its high risk of morbidity and mortality. Role of terlipressin for the management of liver cirrhosis–related complications has been recognized during recent years.
Xingshun Qi +40 more
doaj +2 more sources
Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome [PDF]
Clinical and Molecular Hepatology, 2013 Terlipressin is a vasopressin analogue that is widely used in the treatment of hepatorenal syndrome or variceal bleeding. Because it acts mainly on splanchnic vessels, terlipressin has a lower incidence of severe ischemic complications than does ...
Hae Rim Kim +13 more
doaj +3 more sources
Mapping the hemodynamic effects of terlipressin in patients with hepatorenal syndrome using advanced magnetic resonance imaging [PDF]
JHEP ReportsBackground & aims: Terlipressin improves renal function in ∼40% of patients with hepatorenal syndrome–acute kidney injury (HRS-AKI). Nonetheless, the pathophysiological mechanisms of terlipressin remain unclear.
Karen Vagner Danielsen +10 more
doaj +2 more sources
A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension [PDF]
JGH Open, 2020 Background and Aim To explore the risk factors of hyponatremia caused by terlipressin. Methods Forty‐four patients with acute variceal bleeding treated with terlipressin from December 2016 to December 2018 were analyzed.
Xv Han +4 more
doaj +2 more sources
The use of terlipressin to treat refractory hypotension during allograft kidney transplantation: a report of 4 cases and literature review [PDF]
BMC AnesthesiologyBackground Intraoperative hypotension is a recognized risk factor for delayed graft function (DGF) after kidney transplantation and may compromise both short- and long-term allograft outcomes.
Wen-He Yang +6 more
doaj +2 more sources
Terlipressin for septic shock patients: a meta-analysis of randomized controlled study [PDF]
Journal of Intensive Care, 2019 Background Catecholamines are commonly used in septic shock but face limitations of their hypo-responsiveness and adverse events due to high dose. Terlipressin is a synthetic vasopressin analog with greater selectivity for the V1-receptor.
Yibing Zhu +3 more
doaj +2 more sources
Adjunctive terlipressin versus placebo in the treatment of refractory septic shock: a randomized, placebo-controlled trial. [PDF]
Crit CareTongyoo S +3 more
europepmc +3 more sources